EP
MLAB icon

Essential Partners’s Mesa Laboratories MLAB Stock Holding History

Essential Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.37K Sell
74
-50
-40% -$5.03K ﹤0.01% 1358
2026
Q1 		$11K Buy
124
+110
+786% +$9.48K ﹤0.01% 1215
2025
Q4 		$1.1K Buy
14
+7
+100% +$532 ﹤0.01% 2000
2025
Q3 		$469 Buy
+7
New +$504 ﹤0.01% 2221

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Essential Partners's MLAB Position: Q2 2026 in Review

Essential Partners reduced its Mesa Laboratories (MLAB) stake by 40% in Q2 2026, selling an estimated $5.03K and leaving 74 shares worth $7.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Essential Partners first reported a position in MLAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $11K in Q1 2026. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Essential Partners held 74 shares of Mesa Laboratories worth $7.37K as of Q2 2026.
  • Essential Partners sold 50 Mesa Laboratories shares in Q2 2026, an estimated $5.03K.
  • Mesa Laboratories made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1358 holding.
  • Essential Partners first reported a position in Mesa Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Mesa Laboratories position peaked at $11K in Q1 2026.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.